The G7 15-day sensor has an overall mean absolute relative difference, or MARD, of 8.0%. MARD measures how often the readings from the CGM sensor differ from a blood glucose test. The Dexcom G7 ...

FDA clears Dexcom G7 15-Day CGM for adults, offering 15.5 days of wear and a MARD of 8.0% for improved diabetes management. New features include Apple Watch connectivity, medication logging, and ...

Comprehensive clinical performance study encompassed 646 participant visits, including both Type 2 diabetic patients and healthy volunteers Magnetohydrodynamic (MHD) technology achieves 11.5% MARD ...

On the held-out test dataset, blood glucose was estimated with a MARD of 11.1 ± 2.1% relative to venous blood. Similar accuracy was observed in normoglycemic (11.0 ± 2.7%) ...